📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial. (2023)

First Author: Heath PT

Attributed to: MRC Centre for Virus Research (MRC CVR) - COVID-19 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciac803

PubMed Identifier: 36210481

Publication URI: http://europepmc.org/abstract/MED/36210481

Type: Journal Article/Review

Volume: 76

Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Issue: 3

ISSN: 1058-4838